[1]罗玉芳,李怀玉,吕森浩,等.肾衰泄浊汤对腺嘌呤致肾阳虚型慢性肾衰竭大鼠下丘脑-垂体-肾上腺轴的影响[J].陕西中医,2024,(9):1161-1165.[doi:DOI:10.3969/j.issn.1000-7369.2024.09.002]
　LUO Yufang,LI Huaiyu,LYU Senhao,et al.Effects of Shenshuai Xiezhuo decoction on HPA axis in rats with chronic renal failure of kidney-yang deficiency caused by adenine[J].,2024,(9):1161-1165.[doi:DOI:10.3969/j.issn.1000-7369.2024.09.002]
点击复制

肾衰泄浊汤对腺嘌呤致肾阳虚型慢性肾衰竭大鼠下丘脑-垂体-肾上腺轴的影响
分享到：

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2024年9期
页码:
1161-1165
栏目:
基础研究
出版日期:
2024-09-05

文章信息/Info

Title:
Effects of Shenshuai Xiezhuo decoction on HPA axis in rats with chronic renal failure of kidney-yang deficiency caused by adenine
作者:
罗玉芳1; 2; 李怀玉1; 3; 吕森浩1; 涂欣欣1; 揭植浪2; 杨军平2
(1.江西中医药大学,江西 南昌 330004; 2.江西中医药大学附属医院,江西 南昌 330006; 3.广州中医药大学第一附属医院,广东 广州 510405)
Author(s):
LUO Yufang; LI Huaiyu; LYU Senhao; TU Xinxin; JIE Zhilang; YANG Junping
(Jiangxi University of Chinese Medicine,Nanchang 330004,China)
关键词:
慢性肾衰竭;  肾衰泄浊汤;  腺嘌呤;  肾阳虚;  下丘脑-垂体-肾上腺轴;  氯沙坦钾
Keywords:
Chronic renal failure;  Shenshuai Xiezhuo decoction;  Adenine;  Kidney-yang deficiency;  Hypothalamic-pituitary-adrenal axis;  Losartan potassium
分类号:
R 692
DOI:
DOI:10.3969/j.issn.1000-7369.2024.09.002
文献标志码:
A
摘要:
目的:评估肾衰泄浊汤对腺嘌呤灌胃致慢性肾衰竭(CRF)大鼠肾阳虚相关指标及下丘脑-垂体-肾上腺(HPA)轴的影响。方法:将大鼠随机分为正常组、模型组、中药低、中、高剂量组及西药组,采用腺嘌呤灌胃构建肾阳虚型CRF大鼠模型。造模结束后,中药低、中、高剂量组分别给予不同浓度的肾衰泄浊汤(9.375、18.75、37.5 g/kg),西药以氯沙坦钾作为阳性对照,正常组给予0.9%氯化钠溶液,每天1次,连续28 d。观察大鼠的一般活动,记录体重、尿量和饮水量指标; 检测血清中的血肌酐(Scr)和血尿素氮(BUN)含量; HE染色观察肾组织病理改变; 采用ELISA法测定大鼠血清中促肾上腺皮质激素释放激素(CRH)、促肾上腺皮质激素(ACTH)以及皮质酮(CORT)的含量水平。结果:肾衰泄浊汤能改善CRF大鼠肾阳虚相关的弓背蜷缩、背部发凉、爬行缓慢、反应迟钝和体重增长缓慢表现,降低饮水量和尿量; 减轻肾组织病理破坏,降低血清Scr和BUN水平; 提高血清CRH、ACTH和CORT的含量。结论:肾衰泄浊汤能减轻腺嘌呤致CRF大鼠的肾阳虚证型相关表现,降低血清中的Scr与BUN含量,减轻肾组织病理损伤,并提高HPA轴中的CRH、ACTH和CORT水平。
Abstract:
Objective:To evaluate the effects of Shenshuai Xiezhuo decoction on indexes related to kidney-yang deficiency and hypothalamic-pituitary-adrenal(HPA)axis of chronic renal failure(CRF)induced by adenine gavage model.Methods:SD rats were randomly divided into normal group,model group,low-dose,medium-dose,high-dose Chinese medicine group and western medicine group with 10 rats each.The Kidney-Yang deficiency CRF rat model was established by adenine administration.At the end of modeling,the low,medium and high concentration groups were given different concentrations of Shenshuai Xiezhuo decoction(9.375,18.75 and 37.5 g/kg),losartan potassium was used as positive control,and normal group was given normal saline once a day for 28 consecutive days.The general activities of rats were observed,and the indexes of body weight,urine volume and water intake were recorded.The contents of Scr and BUN in serum were detected.The pathological changes of renal tissue were observed by HE staining.The levels of CRH,ACTH and CORT in serum of rats were determined by ELISA.Results:Shenshuai Xiezhuo decoction could improve the performance of crouching back,cold back,slow crawling,slow reaction and slow growth of body mass,and reduce water and urine volume related to kidney-yang deficiency in CRF rats.The pathological destruction of renal tissue was alleviated and serum Scr and BUN levels were decreased.The contents of CRH,ACTH and CORT in serum were increased.Conclusion:Shenshuai Xiezhuo decoction can alleviate the related manifestations of kidney-yang deficiency syndrome in adenine-induced CRF rats,reduce the content of Scr and BUN in serum,alleviate the pathological injury of kidney tissue,and increase the levels of CRH,ACTH and CORT in HPA axis.

参考文献/References:

[1] JAGER K J,FRASER S D S.The ascending rank of chronic kidney disease in the global burden of disease study[J].Nephrol Dial Transplant,2017,32(s2):ii121-ii128.
[2] GBD 2013 Mortality and Causes of Death Collaborators.Global,regional,and national burden of chronic kidney disease,1990-2017:A systematic analysis for the Global Burden of Disease Study 2017[J].Lancet,2020,395(10225):709-733.
[3] FOREMAN K J,MARQUEZ N,DOLGERT A,et al.Forecasting life expectancy,years of life lost,and all-cause and cause-specific mortality for 250 causes of death:Reference and alternative scenarios for 195 countries and territories[J].Lancet,2018,392(10159):2052-2090.
[4] CHUASUWAN A,POORIPUSSARAKUI S,THAKKINSTIAN A,et al.Comparisons of quality of life between patients underwent peritoneal dialysis and hemodialysis:A systematic review and meta-analysis[J].Health Qual Life Outcomes,2020,18(1):191.
[5] HO Y F,LI I C.The influence of different dialysis modalities on the quality of life of patients with end-stage renal disease:A systematic literature review[J].Psychol Health,2016,31(12):1435-1465.
[6] DAVISON S N,JHANGRI G S,JOHNSON J A.Cross-sectional validity of a modified Edmonton symptom assessment system in dialysis patients:A simple assessment of symptom burden[J].Kidney Int,2006,69(9):1621-1625.
[7] DAVISON S N.Pain in hemodialysis patients:Prevalence,cause,severity,and management[J].Am J Kidney Dis,2003,42(6):1239-1247.
[8] PEREIRA B D S,FERNANDES N D S,DE MELO N P,et al.Beyond quality of life:A cross sectional study on the mental health of patients with chronic kidney disease undergoing dialysis and their caregivers[J].Health Qual Life Outcomes,2017,15(1):74.
[9] 赵万超,远方.辽宁地区523例慢性肾衰竭患者中医证型特征分析[J].云南中医中药杂志,2015,36(3):21-23.
[10] 傅晓晴,林若勤,武一曼,等.腺嘌呤制作肾阳虚型慢性肾功能衰竭大鼠模型的生化研究[J].福建中医学院学报,2003,13(1):22-24.
[11] 傅晓晴,武一曼,陈振彬,等.腺嘌呤制作肾阳虚型慢性肾功能衰竭大鼠模型的电镜病理学研究[J].福建中医学院学报,2002,12(3):41-43.
[12] 郑平东,朱燕俐,丁名城,等.腺嘌呤诱发“肾阳虚”动物模型的研制[J].中国医药学报,1990,5(3):68-73.
[13] 吴国庆,皮持衡.皮持衡教授治疗慢性肾衰竭经验[J].亚太传统医药,2020,16(3):84-86.
[14] 陈东旭.肾衰泻浊汤对慢性肾衰大鼠微血管毁损调节机制的研究[D].南昌:江西中医药大学,2019.
[15] 杨军平,邱丽瑛,魏固伟,等.肾衰泻浊汤对肾衰竭大鼠内皮细胞损伤的保护[J].中国组织工程研究,2012,16(31):5828-5832.
[16] 喻信林.肾衰泄浊汤抗Ang-Ⅱ诱导的肾小球内皮细胞损伤的机制研究[D].南昌:江西中医药大学,2019.
[17] 李怀玉,邱丽瑛,陈微,等.肾衰泄浊汤对腺嘌呤致慢性肾衰大鼠TGF-β1/Smads通路的影响[J].世界科学技术-中医药现代化,2023,25(5):1743-1749.
[18] 李晓娟,白晓晖,陈家旭,等.中医动物模型研制方法及展望[J].中华中医药杂志,2014,29(7):2263-2266.
[19] 李鹏飞,李思汉,陈扬荣,等.慢性肾衰竭病证结合动物模型的研究与思考[J].中国中医基础医学杂志,2020,26(8):1073-1075,1129.
[20] 张子怡,陈宝军,张庆,等.肾阳虚证动物模型的造模方法与评价指标[J].福建中医药,2014,45(2):61-63.
[21] 陈英华,欧阳轶强,孙琪,等.肾阳虚证动物模型规范化研究中诊断指标选择的初步探讨[J].中国中医基础医学杂志,2003,9(10):26-30.
[22] 沈自尹.肾阳虚证的定位研究[J].中国中西医结合杂志,1997,17(1):50-52.
[23] 童骏峰,徐志伟,杨元宵,等.腺嘌呤与氢化可的松所致大鼠肾阳虚证模型比较研究[J].中华中医药杂志,2015,30(11):3901-3904.
[24] 冯莉婷,周蓓,陈誉丹,等.西江桂和清化桂对肾阳虚大鼠HPA轴、HPG轴的影响[J].中药新药与临床药理,2021,32(4):499-504.
[25] 胡珏,李芳芳,陈丹飞,等.基于“肾藏志”理论对补肾法调控儿童注意缺陷多动障碍下丘脑-垂体-肾上腺轴的探究[J].陕西中医,2023,44(9):1265-1268.
[26] OYOLA M G,HANDA R J.Hypothalamic-pituitary-adrenal and hypothalamic-pituitary-gonadal axes:Sex differences in regulation of stress responsivity[J].Stress,2017,20(5):476-494.
[27] SMITH S M,VALE W W.The role of the hypothalamic-pituitary-adrenal axis in neuroendocrine responses to stress[J].Dialogues Clin Neurosci,2006,8(4):383-395.

相似文献/References:

[1]郑 栓,万红波,郑建国,等.健脾补肾活血泄浊方联合杂合式血液净化疗法对慢性肾衰竭患者 肾功能及血清CD4+/CD8+水平的影响*[J].陕西中医,2019,(2):188.
　ZHENG Shuan,WAN Hongbo,ZHENG Jianguo,et al.Effect of Jianpi Bushen Huoxue Xiezhuo decoction combined with hybrid blood purification therapy on renal function and serum CD4+/CD8+ levels in patients with chronic renal failure[J].,2019,(9):188.
[2]张春艳,李 浩,李 娜,等.肾浊清颗粒含药血清对肾小管上皮细胞TGFβ/Smads信号传导的影响*[J].陕西中医,2019,(10):1323.
　ZHANG Chunyan,LI Hao,LI Na,et al.Effect of Shenzhuoqing granulecontaining serum on TGFβ/Smads signal transduction in renal tubular epithelial cells[J].,2019,(9):1323.
[3]王世卫,韩 佳,马民凯△,等.健脾补肾活血化瘀法治疗慢性肾功能衰竭疗效及对患者肾功能的影响*[J].陕西中医,2020,(11):1598.[doi:DOI:10.3969/j.issn.1000-7369.2020.11.022]
[4]陈小燕,杨敏生,曹 雯.肾衰复元汤治疗慢性肾衰竭疗效观察[J].陕西中医,2021,(10):1397.[doi:DOI:10.3969/j.issn.1000-7369.2020.10.018]
[5]李慧灵,张建德,叶 静,等.加味玉液汤治疗气阴两虚型糖尿病肾病慢性肾衰竭疗效及对患者微炎症状态的影响[J].陕西中医,2022,(8):1064.[doi:DOI:10.3969/j.issn.1000-7369.2022.08.018]
[6]王艳芬,马 琴,王 顺.肾康注射液联合穴位敷贴治疗慢性肾功能衰竭疗效及作用机制[J].陕西中医,2023,(5):595.[doi:DOI:10.3969/j.issn.1000-7369.2023.05.012]
　WANG Yanfen,MA Qin,WANG Shun.Effects and mechanism of action of Shenkang injection combined with acupoint application on chronic renal failure[J].,2023,(9):595.[doi:DOI:10.3969/j.issn.1000-7369.2023.05.012]
[7]郭传琦,艾 健.温肾泄浊汤治疗慢性肾衰竭73例疗效研究[J].陕西中医,2023,(9):1237.[doi:DOI:10.3969/j.issn.1000-7369.2023.09.018]
　GUO Chuanqi,AI Jian.Effect of Wenshen Xiezhuo decoction on chronic renal failure[J].,2023,(9):1237.[doi:DOI:10.3969/j.issn.1000-7369.2023.09.018]
[8]刘文君,王亿平,吕 伟,等.益气护肾方佐治慢性肾衰竭3～5期肾气虚夹瘀临床研究[J].陕西中医,2024,(8):1056.[doi:DOI:10.3969/j.issn.1000-7369.2024.08.010]
　LIU Wenjun,WANG Yiping,LYU Wei,et al.Clinical efficacy of Yiqi Hushen decoction adjuvant therapy on patients with stage 3～5 chronic renal failure with syndrome of kidney deficiency and blood stasis[J].,2024,(9):1056.[doi:DOI:10.3969/j.issn.1000-7369.2024.08.010]

备注/Memo

备注/Memo:
基金项目:国家自然科学基金资助项目(81260578); 江西省自然科学基金资助重点项目(20232ACB206055)
更新日期/Last Update: 2024-09-09